JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Sunless Tanners in Dermatology: A Review of Ingredients, Efficacy, and Safety Profiles

Published online December 19, 2025

Sunless tanners offer an alternative to traditional tanning methods that involve exposure to ultraviolet (UV) radiation. Dermatologists...

read more
Halo Seborrheic Keratosis in a Patient of Color With Vitiligo

Published online December 15, 2025

Practice Points Depigmented halos are not restricted to melanocytic lesions; SK can rarely display a halo and may clinically r...

read more
Social Media Analysis of #LipFiller: Content and Quality

Published online December 15, 2025

The popularity of fillers for lip enhancement—commonly referred to as "lip fillers"--has grown substantially in recent years. 1,2...

read more
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Published online December 11, 2025

Axillary hyperhidrosis is a chronic dermatological condition characterized by excessive underarm sweating, often interfering with daily...

read more
FDA Boxed Warnings: Should Package Inserts Include Levels of Evidence?

Published online November 30, 2025

New medications are continuously being developed for the treatment of various disorders. The US Food and Drug Administration (FDA) ...

read more
An Open-Label, Single-Center Proof of Concept Study Evaluating the Efficacy and Safety of Tirzepatide for Moderate to Severe Hidradenitis Suppurativa

Published online November 25, 2025

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder of the pilosebaceous unit, characterized by deep, tender, purulen...

read more
Skin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments

Published online November 30, 2025

With an estimated prevalence of 9.4% globally, acne vulgaris (hereafter referred to as acne) is one of the most common cutaneous diseas...

read more
More Than Skin Clearance: Connecting Brodalumab's Mechanism of Action to Patient Outcomes in Psoriasis

Published online November 25, 2025

Moderate-to-severe psoriasis is associated with substantial burden, including increased depression and anxiety and reduced quality of ...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

JDD December Highlights and Editor Picks

| Featured Articles, JDD Highlights, Latest News | No Comments
Curated by the JDD Editors Missed any of our December highlights? December is our Immunodermatology issue and it’s packed with intriguing articles–start to dive in! Catch up with this curated…

The Best Sunscreen is the One Your Patients Will Use and Other Truths

| JDD Highlights, JDD Webinars, The Latest, Video Abstract | No Comments
Behind all sunscreen is a scientific story, the photobiology, toxicology and public perception.  Yet, the science often gets lost in the noise of misconceptions and outdated narratives.  Join Adam Friedman…

Impact of Low-Dose Oral Minocycline (DFD-29) on Skin, Gastrointestinal, and Vaginal Microflora in Healthy Adults

| Featured Articles, Latest News, Rosacea, Women | No Comments
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…
Journal of Drugs in Dermatology JDD Article about The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

| Featured Articles, Latest News, Skin Cancer | No Comments
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Journal of Drugs in Dermatology JDD Article about GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

| Acne, Featured Articles, Latest News, Medical Derm | No Comments
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

The Nuts and Bolts (or Berries) of Nutraceutical Regulation and Development: A Natural Review

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Isabelle Raymond, PhD Supplements, serums, infused soaps oh my! The over the counter space is a vast dermatology multiverse which can easily knock you off your axis…
Tune In

Follow Us